Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to 0.17.

  • Biofrontera's Equity Ratio fell 15606.17% to 0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17, marking a year-over-year decrease of 15606.17%. This contributed to the annual value of 0.2 for FY2024, which is 1689.08% up from last year.
  • According to the latest figures from Q3 2025, Biofrontera's Equity Ratio is 0.17, which was down 15606.17% from 0.23 recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Equity Ratio peaked at 0.51 during Q2 2024, and registered a low of 1.13 during Q3 2021.
  • Moreover, its 5-year median value for Equity Ratio was 0.21 (2021), whereas its average is 0.1.
  • As far as peak fluctuations go, Biofrontera's Equity Ratio soared by 88126.41% in 2024, and later crashed by 15606.17% in 2025.
  • Over the past 5 years, Biofrontera's Equity Ratio (Quarter) stood at 0.21 in 2021, then soared by 120.27% to 0.47 in 2022, then crashed by 63.43% to 0.17 in 2023, then rose by 16.89% to 0.2 in 2024, then plummeted by 183.48% to 0.17 in 2025.
  • Its last three reported values are 0.17 in Q3 2025, 0.23 for Q2 2025, and 0.03 during Q1 2025.